Hyloris reports full year results for 2022 & provides
Strong R&D progress & attractive commercial deals, including additional Tranexamic Acid RTU out-licensing
Globe Newswire16-03-2023, 01:08
Nasdaq Study Shows Legacy Technology and Regulation Preventing Financial Institutions From Capturing Growth Opportunities 14-09-2023, 15:00